Weight-Loss Drugs Found to Reduce Alcohol Cravings

A growing number of people using weight-loss medications such as semaglutide — marketed under names including Ozempic and Wegovy — are reporting an unexpected side effect: a sharp reduction in their desire to drink alcohol. Some describe no longer craving it at all, while others say they feel sick when they drink even small amounts.

How the Drugs Work

GLP-1 receptor agonists like semaglutide were originally developed to manage blood sugar in type 2 diabetes patients, and later approved for weight loss. They appear to work in the brain's reward system, reducing cravings not just for food but potentially for other substances including alcohol.

Personal Accounts

Users interviewed for the BBC story described the change as striking. Several said they had previously drunk regularly without concern, but after starting weight-loss medication noticed they no longer enjoyed alcohol or experienced feelings of nausea after a single drink.

Scientific Interest

Researchers are taking the anecdotal reports seriously. Some clinical trials are now underway exploring whether GLP-1 drugs could be used therapeutically to treat alcohol use disorder. Early results are promising, but experts caution that more rigorous study is needed before any clinical recommendations can be made.

The potential dual use of these drugs — for weight management and possibly addiction — represents a significant new frontier in medical research. Addiction specialists say the findings could be transformative if the effect proves consistent across larger patient groups.